Boothbay Fund Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $40K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $165K | Buy |
|
|||||
|
2020
Q4 | $43K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $13K | Hold |
|
|||||
|
2020
Q1 | $20K | Hold |
|
|||||
|
2019
Q4 | $16K | Hold |
|
|||||
|
2019
Q3 | $35K | Hold |
|
|||||
|
2019
Q2 | $35K | Hold |
|
|||||
|
2019
Q1 | $59K | Hold |
|
|||||
|
2018
Q4 | $20K | Sell |
|
|||||
|
2018
Q3 | $100K | Hold |
|
|||||
|
2018
Q2 | $106K | Hold |
|
|||||
|
2018
Q1 | $137K | Buy |
|
|||||
|
2017
Q4 | $144K | Buy |
|
|||||
|
2017
Q3 | $63K | Hold |
|
|||||
|
2017
Q2 | $88K | Buy |
|
|||||
|
2017
Q1 | $81K | Hold |
|
|||||
|
2016
Q4 | $72 | Buy |
|
|||||
|
2016
Q3 | $70K | Buy |
|